From Yahoo Finance: 2025-05-23 12:46:00

Genentech is investing over $700m in a new manufacturing facility in North Carolina, creating 1,500 construction jobs and 400 permanent positions. This move aligns with Roche’s plan to invest $50bn in US pharmaceuticals. However, a new executive order on drug pricing could impact Roche’s investment plans.

Roche reported an 8% sales increase in Q1 2025, driven by key drugs like Phesego and Xolair. Genentech’s expansion reflects a trend of US-based manufacturing investments to counter global challenges. Despite debates over drug pricing policies, Roche remains committed to its $50bn investment in US pharmaceuticals.



Read more at Yahoo Finance: Genentech to onshore US manufacturing amid rising drug pricing tensions